A research team led by Prof. Ben Ko Chi-bun, Associate Professor of the PolyU Department of Applied Biology and Chemical Technology, has discovered the critical mechanism of action of tetrandrine, a ...
CHIP at a VAF of 10% or greater is the strongest predictor of whether daily low-dose aspirin can help prevent cancer in healthy, older adults.
Lynkuet is the first FDA-approved therapy that blocks both the neurokinin 1 and neurokinin 3 receptors to treat hot flashes.
Clearance of Lynkuet provides a new alternative to hormone-based treatment for hot flashes and sets up a market battle with ...
Reuters on MSN
US FDA approves Bayer's menopause relief drug
The drug, branded as Lynkuet, is a non-hormonal treatment designed to relieve moderate-to-severe vasomotor symptoms, also ...
The Thai Cement Manufacturers Association (TCMA) presented its perspectives from the cement industry at the Thailand Climate Action Conference 2025 (TCAC 2025), highlighting that clear policies, laws, ...
TipRanks on MSN
Bayer’s New Study on Finerenone: A Potential Game-Changer for Pediatric Heart Failure
Bayer AG (($BAYRY)) announced an update on their ongoing clinical study. Study Overview: Bayer AG is conducting a Phase 3, single-arm, open-label ...
Speaking to reporters on the sidelines of Wednesday’s Cabinet session, Mohajerani said the administration and the diplomatic apparatus have exerted all efforts to prevent the activation of the ...
Bayer AG (($BAYRY)) announced an update on their ongoing clinical study. Study Overview: Bayer AG is conducting an observational study titled ‘The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results